RAPT Therapeutics Inc (RAPT)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current RAPT market cap is 104.29M. The company's latest EPS is USD -0.9838 and P/E is -0.80.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -33.22M | -32.52M | -29.33M | -19.79M | -54.47M |
| Net Income | -30.88M | -30.52M | -27.66M | -18.43M | -53.25M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.04M | 3.81M | 1.53M | 0 | 0 |
| Operating Income | -53.21M | -69.21M | -85.8M | -127.06M | -136.1M |
| Net Income | -52.89M | -69.2M | -83.84M | -116.8M | -129.87M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 173.33M | 155.82M | 127.18M | 108.47M | 240.33M |
| Total Liabilities | 26.29M | 24.98M | 17.96M | 12.96M | 50.42M |
| Total Equity | 147.04M | 130.84M | 109.22M | 95.51M | 189.9M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 118.97M | 198.64M | 266.21M | 173.33M | 240.33M |
| Total Liabilities | 14.79M | 12.26M | 21.04M | 26.29M | 50.42M |
| Total Equity | 104.18M | 186.38M | 245.17M | 147.04M | 189.9M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -97.05M | -27.08M | -55.24M | -72.86M | -83.3M |
| Investing | 104.13M | 15.89M | 35.1M | 53.55M | 52.7M |
| Financing | 1.45M | 9.04M | 9.74M | 9.74M | 152.85M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -40.49M | -61.03M | -70.77M | -97.05M | -83.3M |
| Investing | -87.44M | -81.35M | -45.49M | 104.13M | 52.7M |
| Financing | 75.46M | 141.48M | 131.18M | 1.45M | 152.85M |
| Market Cap | 104.29M |
| Price to Earnings Ratio | -0.80 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.61 |
| Price to Book Ratio | 0.55 |
| Dividend Yield | - |
| Shares Outstanding | 132.01M |
| Average Volume (1 week) | 1.06M |
| Average Volume (1 Month) | 859.87k |
| 52 Week Change | -90.13% |
| 52 Week High | 8.58 |
| 52 Week Low | 0.75345 |
| Spread (Intraday) | 0.04 (4.44%) |
| Company Name | RAPT Therapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.rapt.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
